4534 — Mochida Pharmaceutical Share News
0.000.00%
Last trade - 00:00- ¥116bn
- ¥98bn
- ¥117bn
Table: Mochida Pharm - 6-MTH group results
Table: Mochida Pharm -Q1 group results
Brief: Amarin And Mochida Announce Collaboration On Future Development Of EPA-Based Drug Products And Indications
Table: Mochida Pharm -2017/18 group results
Table: Mochida Pharm -2017/18 parent results
Table: Mochida Pharm -2017/18 group forecast
Brief: Mochida Pharmaceutical to retire treasury shares
Table: Mochida Pharm - 9-MTH group results
Table: Mochida Pharm - 6-MTH group results
Table: Mochida Pharm -Q1 group results
Brief: Mochida Pharmaceutical signs contract for joint development of sale of gout and hyperuricemia treatment FYU-981 in Japan with FUJIYAKUHIN Co., Ltd.
Brief: Mochida Pharmaceutical to retire 465,000 treasury shares
Brief: Albireo announces submission of new drug application for Elobixibat in Japan
Table: Mochida Pharm -9-MTH group results
Brief: Gene Techno Science signs agreement regarding biosimilar of cancer treatment
Table: Mochida Pharm -2016/17 group forecast
Table: Mochida Pharm -6-MTH group results
2016 6-month group forecast
Brief: Mochida Pharmaceutical gets manufacture and marketing approval for medicine of ulcerative colitis